跳至主要内容
临床试验/IRCT138901013596N1
IRCT138901013596N1已完成2 期

A survey of additive antiproteinuric effect of pentoxifylline on diabetic nephropathy patients with proteinuria taking losartan and enalapril.

research deputy of Ahvaz Jundishapur University0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 no limit(—)
性别
All

入选标准

  • inclusion: diabetic nephropathy with GFR more than 30 ml/min and proteinuria more than 150 mg/24h.
  • exclusion: pentoxifylline sensivity, congestion heart failur, uncontroled HTN, patients that recived new drug with antiprotein effect( non dihydropridine calcium channel blockers, sprinolacton,beta blockers, diuretics) during study.

排除标准

  • 未提供

研究者

发起方
research deputy of Ahvaz Jundishapur University

相似试验